All In MedTech

FDA Clearance Tracker · P030016-S042

EVO/EVO+ VISIAN® Implantable Collamer® Lenses

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 20, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 20, 2022

Approved

Time to decision

46 days

Received Apr 4, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030016-S042
Device name
EVO/EVO+ VISIAN® Implantable Collamer® Lenses
Applicant location
Monrovia, CA
Received
Apr 4, 2022
Decided
May 20, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P030016

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MTA

FDA's approval statement

As written in FDA's record.

Approval of the protocol for the post-approval study (PAS) protocol.

Source documents

Other decisions for STAAR Surgical Company

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.